Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-०.२१%
१,०९१.५१
-२.३०
-०.२१%
—१,०९३.८११,०९६.५२१,१००.२२१,०९१.५१——
SIXC
Communications
SIXC
Communications
SIXC
+०.२२%
६१०.११
+१.३४
+०.२२%
—६०८.७७६०८.७७६१२.९७६०८.७७——
SIXE
Energy
SIXE
Energy
SIXE
-१.३४%
१,२३७.९८
-१६.८३
-१.३४%
—१,२५४.८११,२५३.०११,२५३.८७१,२२६.३३——
SIXI
Industrials
SIXI
Industrials
SIXI
-०.९३%
१,७४४.७१
-१६.४०
-०.९३%
—१,७६१.१११,७६४.२७१,७६६.८८१,७४४.७१——
SIXM
Financials
SIXM
Financials
SIXM
-०.३७%
६४०.१८
-२.४०
-०.३७%
—६४२.५८६४४.८७६४८.४८६४०.१८——
SIXR
Staples
SIXR
Staples
SIXR
-०.१८%
८४९.५८
-१.५५
-०.१८%
—८५१.१३८५५.६६८५८.७५८४५.५६——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-०.२३%
२१७.४८
-०.५०
-०.२३%
—२१७.९८२१७.९८२१८.६५२१६.८८——
SIXT
Technology
SIXT
Technology
SIXT
+१.५२%
३,२६०.६९
+४८.८६
+१.५२%
—३,२११.८३३,२२७.२१३,२६८.३८३,२२६.५५——
SIXU
Utilities
SIXU
Utilities
SIXU
-०.६९%
९४२.४५
-६.५३
-०.६९%
—९४८.९८९४८.५८९५७.८३९४१.९७——
SIXV
Health care
SIXV
Health care
SIXV
-०.५२%
१,४६६.८०
-७.७२
-०.५२%
—१,४७४.५२१,४७९.०३१,४८१.०४१,४६६.८०——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+०.२२%
२,३९७.५०
+५.३८
+०.२२%
—२,३९२.१२२,३९६.९५२,४२१.२२२,३८२.३२——
RHO1:FRA
Roche CAD Hedged CDR
€ ७.३०
-०.६८%
(-०.०५०) 1D
अप्रिल ३०, २२:००:०० GMT+२  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for RHO1...
Open
€ ७.३०
High
€ ७.३०
Low
€ ७.३०
Mkt. cap
३.३१ खरब
Avg. vol.
१०.००
Volume
०.००
52-wk high
€ ८.५५
52-wk low
€ ५.३०
No. of employees
१ लाख
News stories
From sources across the web
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76. The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021. F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche CAD Hedged CDR
CEOThomas Schinecker
Employees१.१३ लाख
Founded१८९६ अक्टोबर १
Headquartersबेसेल, Basel City, स्विट्जरल्यान्ड
Sector-
Websiteroche.com
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
२०२५ मार्च
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
Revenue
१५.९२ अरब
१५.९२ अरब
१५.७५ अरब
१५.७५ अरब
Cost of goods sold
३.८७ अरब
३.८७ अरब
४.२१ अरब
४.२१ अरब
Cost of revenue
३.८७ अरब
३.८७ अरब
४.२१ अरब
४.२१ अरब
Research and development expenses
३.११ अरब
३.११ अरब
३.१५ अरब
३.१५ अरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३.२९ अरब
३.२९ अरब
३.५९ अरब
३.५९ अरब
Operating expense
६.३० अरब
६.३० अरब
६.८२ अरब
६.८२ अरब
Total operating expenses
१०.१७ अरब
१०.१७ अरब
११.०३ अरब
११.०३ अरब
Operating income
५.७५ अरब
५.७५ अरब
४.७२ अरब
४.७२ अरब
Other non operating income
४०.०० लाख
४०.०० लाख
-१५.०० लाख
-१५.०० लाख
EBT including unusual items
४.७९ अरब
४.७९ अरब
३.६९ अरब
३.६९ अरब
EBT excluding unusual items
५.४६ अरब
५.४६ अरब
४.३७ अरब
४.३७ अरब
Income tax expense
८७.८० करोड
८७.८० करोड
७०.९० करोड
७०.९० करोड
Effective tax rate
१८.३१%
१८.३१%
१९.२०%
१९.२०%
Other operating expenses
-११.०५ करोड
-११.०५ करोड
७.७५ करोड
७.७५ करोड
Net income
३.७० अरब
३.७० अरब
२.७४ अरब
२.७४ अरब
Net profit margin
२३.२७%
२३.२७%
१७.३६%
१७.३६%
Earnings per share
-
-
-
-
Interest and investment income
५.६५ करोड
५.६५ करोड
४.५० करोड
४.५० करोड
Interest expense
-३०.४० करोड
-३०.४० करोड
-२८.९५ करोड
-२८.९५ करोड
Net interest expenses
-२४.७५ करोड
-२४.७५ करोड
-२४.४५ करोड
-२४.४५ करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
६.५३ अरब
६.५३ अरब
५.५० अरब
५.५० अरब
Gain or loss from assets sale
-
-
-२.१५ करोड
-२.१५ करोड
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer